Literature DB >> 7771522

ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop.

G Wolf1, F N Ziyadeh, U Helmchen, G Zahner, R Schroeder, R A Stahl.   

Abstract

A murine SV40-transformed renal epithelial cell line derived from medullary thick ascending limb of Henle's loop (MTAL) was established and characterized by morphology, antigen expression, and biochemical criteria. These MTAL cells express a single class of high-affinity receptors for angiotensin II (ANG II) and transcripts for the AT1 subtype of ANG II receptors. ANG II, in a dose-dependent manner, induced proliferation of MTAL cells. This observation is in striking contrast to syngeneic proximal tubular cells in which it was previously shown that the peptide induced cellular hypertrophy and slightly inhibited proliferation [G. Wolf and E. G. Neilson. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28: F768-F777, 1990]. The AT1-receptor antagonist losartan (10(-6) M), but not an AT2-receptor antagonist, blocked the mitogenic effects of ANG II in MTAL cells. Coincubation of quiescent MTAL cells with ANG II and 5% fetal calf serum further increased proliferation compared with cells grown only in serum. In contrast to proximal tubular cells, ANG II failed to induce transforming growth factor-beta 1 mRNA and protein synthesis in MTAL cells. Our data collectively suggest that ANG II is a mitogen for MTAL cells in vitro. Therefore, epithelial cells derived from different parts of the nephron, even when transformed with SV40 virus and while under cell culture conditions, exhibit a distinct pattern of growth behavior after stimulation with ANG II.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771522     DOI: 10.1152/ajprenal.1995.268.5.F940

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Regulation of angiotensin II receptors in the medullary thick ascending limb.

Authors:  D H Wang; J Li
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Angiotensin II attenuates renal cortical cyclooxygenase-2 expression.

Authors:  H F Cheng; J L Wang; M Z Zhang; Y Miyazaki; I Ichikawa; J A McKanna; R C Harris
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells.

Authors:  Silvia Kelsen; Bijal J Patel; Lawson B Parker; Trinity Vera; John M Rimoldi; Rama S V Gadepalli; Heather A Drummond; David E Stec
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

4.  Genetic Association Study of Angiotensin II Receptor Types 1 (A168G) and 2 (T1247G and A5235G) Polymorphisms in Breast Carcinoma among Brazilian Women.

Authors:  Maria Del Carmen Garcia Molina Wolgien; Ismael Dale Cotrim Guerreiro da Silva; Afonso Celso Pinto Nazário; Clovis Riuche Nakaie; Silvana Aparecida Alves Correa-Noronha; Samuel Marcos Ribeiro de Noronha; Gil Facina
Journal:  Breast Care (Basel)       Date:  2014-07       Impact factor: 2.860

5.  Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells.

Authors:  Shelby C Young; Megan V Storm; Joshua S Speed; Silvia Kelsen; Chelsea V Tiller; Trinity Vera; Heather A Drummond; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-16       Impact factor: 3.619

6.  Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl salt-sensitive rat.

Authors:  Chun Yang; Francesco C Stingo; Kwang Woo Ahn; Pengyuan Liu; Marina Vannucci; Purushottam W Laud; Meredith Skelton; Paul O'Connor; Terry Kurth; Robert P Ryan; Carol Moreno; Shirng-Wern Tsaih; Giannino Patone; Oliver Hummel; Howard J Jacob; Mingyu Liang; Allen W Cowley
Journal:  Hypertension       Date:  2012-11-26       Impact factor: 10.190

7.  Diabetic microvascular complications: possible targets for improved macrovascular outcomes.

Authors:  John A D'Elia; George Bayliss; Bijan Roshan; Manish Maski; Ray E Gleason; Larry A Weinrauch
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.